V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014042 | 270009626 | 1.76 | 60 | Palliative (P) | 2014-10-14 | 2014-10-14 | Cisplatin +Fluorouracil (3 wk) | N | N | 270016488 | CISPLATIN + FLUOROURACIL |
| 270014043 | 270009633 | null | 84 | Curative (C) | 2016-07-07 | 2016-07-07 | Capecitabine 35days + RT | 02 | N | 270016500 | CAPECITABINE + RT |
| 270014044 | 270009634 | 0 | 66 | Curative (C) | 2018-01-28 | 2018-05-07 | Shamash LBCMVD-56 | N | null | 270016502 | NOT MATCHED |
| 270014045 | 270014509 | null | null | Palliative (P) | 2014-01-29 | 2014-06-25 | CETUXIMAB + RT | N | N | 270016502 | CETUXIMAB + RT |
| 270014046 | 270014509 | 1.76 | 71 | Adjuvant (A) | 2015-08-22 | 2015-08-22 | CHLVPP | N | N | 270016502 | CHLVPP |
| 270014047 | 270014509 | 1.69 | 70.9 | Adjuvant (A) | 2014-07-25 | 2014-08-22 | Cetuximab + Radiotherapy Maint | 99 | null | 270016502 | CETUXIMAB + RT |
| 270014048 | 270014509 | 1.81 | 60.8 | Curative (C) | 2016-11-08 | 2016-12-30 | CHOP R - 21 days | N | null | 270016502 | CHOP R |
| 270014049 | 270014509 | 1.71 | 69.4 | Curative (C) | 2017-12-07 | 2018-01-04 | Trifluridine + Tipiracil | 02 | N | 270016502 | TRIFLURIDINE + TIPIRACIL |
| 270014050 | 270009636 | 1.8 | 56.3 | Adjuvant (A) | 2017-07-26 | 2017-08-21 | Capecitabine 35days + RT | 02 | Y | 270016521 | CAPECITABINE + RT |
| 270014051 | 270009636 | 1.78 | 64.7 | null | null | 2015-11-11 | null | N | N | 270016521 | NOT MATCHED |
| 270014052 | 270016997 | 1.58 | 64 | Palliative (P) | null | 2016-12-13 | Capecitabine (21 day) + Irinotecan | N | null | 270016525 | CAPECITABINE + IRINOTECAN |
| 270014053 | 270009639 | 1.72 | 85.1 | Palliative (P) | 2018-03-02 | 2018-03-09 | CHLVPP | N | N | 270016528 | CHLVPP |
| 270014054 | 270009642 | 1.9 | 40.1 | Neo-adjuvant (N) | null | 2016-11-02 | Capecitabine (14 day) + Irinotecan | N | null | 270016531 | CAPECITABINE + IRINOTECAN |
| 270014055 | 270009643 | 1.66 | 98.8 | Curative (C) | 2017-06-12 | 2017-06-20 | Cetuximab + Radiotherapy Load | 2 | N | 270016532 | CETUXIMAB + RT |
| 270014056 | 270014511 | 1.69 | 64.8 | Adjuvant (A) | null | 2014-02-26 | Fluorouricil + Folonic Acid (MdG) | null | null | 270016538 | FLUOROURACIL |
| 270014057 | 270014511 | 1.87 | 107.6 | Neo-adjuvant (N) | 2016-02-07 | 2016-02-07 | CAPECITABINE + RT | N | N | 270016538 | CAPECITABINE + RT |
| 270014058 | 270014512 | 1.89 | null | 6 | null | 2016-03-24 | CHLVPP | 02 | N | 270016542 | CHLVPP |
| 270014059 | 270009645 | 1.65 | null | null | 2017-10-23 | 2017-10-29 | CAPECITABINE + IRINOTECAN | null | N | 270016545 | CAPECITABINE + IRINOTECAN |
| 270014060 | 270009647 | 1.79 | null | Curative (C) | 2017-06-04 | 2017-06-05 | CHLVPP | 2 | N | 270016546 | CHLVPP |
| 270014061 | 270009647 | 1.85 | 90.2 | Curative (C) | null | 2017-02-11 | CHLVPP | 02 | null | 270016546 | CHLVPP |
| 270014062 | 270009648 | 1.92 | 72.7 | Curative (C) | 2014-06-02 | 2014-07-08 | CHLVPP | 02 | null | 270016549 | CHLVPP |
| 270014063 | 270009649 | 1.49 | 80 | Palliative (P) | 2017-04-21 | 2017-04-27 | Bevacizumab + Oxaliplatin +MdG | N | N | 270016559 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014064 | 270017002 | null | 63 | Palliative (P) | 2013-07-23 | 2013-10-26 | Cetuximab + Radiotherapy Maint | N | N | 270016568 | CETUXIMAB + RT |
| 270014065 | 270017002 | 1.66 | 47 | Neo-adjuvant (N) | 2014-02-09 | 2014-02-19 | Bevacizumab + Oxaliplatin +MdG | 2 | Y | 270016568 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014066 | 270009653 | 1.62 | null | Palliative (P) | 2015-12-01 | 2015-12-01 | CISPLATIN + FLUOROURACIL | 2 | N | 270016576 | CISPLATIN + FLUOROURACIL |
| 270014067 | 270009653 | null | null | Adjuvant (A) | 2018-03-01 | 2018-08-02 | DHAP | 02 | Y | 270016576 | DHAP |
| 270014068 | 270009654 | null | null | null | 2016-05-28 | 2016-06-02 | FLUOROURACIL + FOLINIC ACID | 2 | N | 270016579 | FLUOROURACIL |
| 270014069 | 270009654 | 1.71 | 60 | Palliative (P) | 2015-03-04 | 2015-03-29 | Bevacizumab + Oxaliplatin +MdG | 02 | N | 270016579 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014070 | 270014519 | 1.61 | 57.2 | Disease modification (D) | 2017-05-08 | 2017-05-08 | CHLVPP | N | N | 270016581 | CHLVPP |
| 270014071 | 270014519 | 1.6 | 60 | Curative (C) | 2015-05-29 | 2015-05-29 | Cetuximab + Radiotherapy Maint | N | N | 270016581 | CETUXIMAB + RT |
| 270014072 | 270009656 | 1.76 | 69 | Curative (C) | 2017-10-20 | 2017-10-21 | DHAP | 02 | N | 270016596 | DHAP |
| 270014073 | 270009657 | 1.8 | 63 | Curative (C) | 2014-02-13 | 2014-02-13 | DHAP | N | Y | 270016596 | DHAP |
| 270014074 | 270009658 | 1.88 | null | Palliative (P) | 2014-11-25 | 2014-11-26 | Bevacizumab + Oxaliplatin +MdG | 02 | Y | 270016598 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 270014075 | 270009661 | null | 56 | Palliative (P) | null | 2017-11-17 | Capecitabine (14 day) + Irinotecan | 99 | null | 270016605 | CAPECITABINE + IRINOTECAN |
| 270014076 | 270009661 | null | null | null | 2017-11-08 | 2017-11-08 | ALCL ALCL 99 Closed Pre Phase | N | N | 270016605 | NOT MATCHED |
| 270014077 | 270018432 | 1.67 | 61.7 | Adjuvant (A) | 2012-06-06 | 2013-03-31 | CHLVPP | N | N | 270016607 | CHLVPP |
| 270014078 | 270009663 | null | null | Adjuvant (A) | 2017-06-07 | 2017-06-22 | Fluorouracil + Folinic Acid Weekly | N | N | 270016608 | FLUOROURACIL |
| 270014079 | 270009663 | 1.83 | null | Palliative (P) | 2017-10-17 | 2017-10-17 | CHOP R - 14 days | N | N | 270016608 | CHOP R |
| 270014080 | 270009667 | 1.71 | 0 | Adjuvant (A) | null | 2018-01-23 | FLUOROURACIL | N | N | 270016617 | FLUOROURACIL |
| 270014081 | 270009669 | 1.62 | 88 | Neo-adjuvant (N) | 2015-06-29 | 2015-07-09 | Capecitabine 35days + RT | 2 | N | 270016619 | CAPECITABINE + RT |
| 270014082 | 270009671 | 1.76 | null | Disease modification (D) | 2018-04-25 | 2018-04-25 | DHAP | N | N | 270016621 | DHAP |
| 270014083 | 270009673 | null | 86.5 | null | 2015-04-30 | 2015-05-10 | CAPECITABINE + IRINOTECAN | N | N | 270016623 | CAPECITABINE + IRINOTECAN |
| 270014084 | 270009675 | 1.75 | 52 | Curative (C) | 2018-05-25 | 2018-06-28 | DHAP | null | null | 270016623 | DHAP |
| 270014085 | 270009675 | 1.76 | 89 | Palliative (P) | 2016-11-16 | 2016-11-21 | CAPECITABINE + IRINOTECAN | N | N | 270016623 | CAPECITABINE + IRINOTECAN |
| 270014086 | 270018435 | 1.52 | null | Adjuvant (A) | 2016-09-17 | 2016-09-17 | CHLVPP | 99 | null | 270016635 | CHLVPP |
| 270014087 | 270017015 | 1.66 | 86.4 | Disease modification (D) | 2015-07-06 | 2017-08-29 | Trifluridine + Tipiracil | N | N | 270016637 | TRIFLURIDINE + TIPIRACIL |
| 270014088 | 270009678 | 1.75 | 60 | Curative (C) | 2018-09-26 | 2018-09-26 | CHLVPP | 02 | N | 270016640 | CHLVPP |
| 270014089 | 270009679 | 1.58 | 67 | Not known (9) | 2018-07-06 | 2018-07-18 | CAPECITABINE + RT | N | N | 270016643 | CAPECITABINE + RT |
| 270014090 | 270009679 | 1.62 | 64.8 | Palliative (P) | 2015-09-02 | 2016-06-07 | Cetuximab + Radiotherapy Maint | 02 | N | 270016643 | CETUXIMAB + RT |
| 270014091 | 270009680 | 1.6 | 64 | Neo-adjuvant (N) | 2015-12-05 | 2015-12-18 | CAPECITABINE + RT | 2 | N | 270016648 | CAPECITABINE + RT |